SCHEMBL19082229

SCHEMBL19082229

c1ccc(-c2c3ccccc3c(-c3ccc(-c4c5sc6ccc7ccccc7c6c5cc5sc6ccccc6c45)cc3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.36
NQO1 P15559 1/20 0.36
DUSP3 P51452 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
PTPN5 P54829 1/20 0.36
PTPN11 Q06124 1/20 0.36
MCL1 Q07820 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PTPN1 P18031 3/20 0.36
CYP1A1 P04798 2/20 0.34
CYP1B1 Q16678 1/20 0.34
TNKS O95271 2/20 0.33
TNKS2 Q9H2K2 2/20 0.33
CHEK1 O14757 1/20 0.33
WEE1 P30291 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082348 0.96 NQO2 (0.34) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082235 0.95 NQO2 (0.35) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082152 0.95 NQO2 (0.35) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082257 0.91 ALOX5 (0.36) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082310 0.91 NQO1 (0.34) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082264 0.87 NQO1 (0.33) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082242 0.87 TNKS (0.40) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082168 0.86 NQO1 (0.33) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL19082187 0.86 CHEK1 (0.35) NQO2NQO1DUSP3MEN1KMT2A
SCHEMBL17945231 0.85 TNKS (0.44) DUSP3MEN1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885DUSP3 4854/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885DUSP3 4854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.